Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.
Fitzgerald KN, Lee CH, Voss MH, Carlo MI, Knezevic A, Peralta L, Chen Y, Lefkowitz RA, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha RR, Feldman DR, Motzer RJ.
Fitzgerald KN, et al. Among authors: lee ch.
Eur Urol. 2024 May 22:S0302-2838(24)02349-2. doi: 10.1016/j.eururo.2024.04.025. Online ahead of print.
Eur Urol. 2024.
PMID: 38782695